Kura Oncology, Inc.
KURA
$9.22
-$0.52-5.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.75% | -8.27% | 20.73% | 28.32% | 24.87% |
| Total Receivables | -74.75% | 135.15% | 664.60% | -2.68% | 1,156.88% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 138.01% | 135.27% | 998.43% | 598.03% | 86.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.87% | -4.86% | 34.00% | 32.08% | 34.65% |
|
|
|||||
| Total Current Assets | -13.87% | -4.86% | 34.00% | 32.08% | 34.65% |
| Net Property, Plant & Equipment | 40.93% | 102.50% | 101.43% | 48.63% | 24.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 54.09% | 85.38% | 67.40% | 42.41% | 18.43% |
| Total Assets | -12.26% | -2.87% | 35.62% | 32.48% | 34.28% |
|
|
|||||
| Total Accounts Payable | 52.78% | 241.52% | 55.39% | -17.44% | -38.77% |
| Total Accrued Expenses | 14.58% | 31.57% | 82.91% | 76.20% | 63.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -66.47% | -71.55% | 69.29% | 107.78% | 180.70% |
| Total Finance Division Other Current Liabilities | 14.54% | 88.36% | -- | -- | -- |
| Total Other Current Liabilities | 14.54% | 88.36% | -- | -- | -- |
| Total Current Liabilities | 13.07% | 48.61% | 200.47% | 220.39% | 178.21% |
|
|
|||||
| Total Current Liabilities | 13.07% | 48.61% | 200.47% | 220.39% | 178.21% |
| Long-Term Debt | 27.44% | 40.41% | -31.21% | -24.10% | -18.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 68.08% | 82.45% | 53.02% | 39.59% | 26.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.32% | 67.41% | 18,379.61% | 21,592.18% | 28,718.51% |
| Total Liabilities | 43.58% | 62.83% | 638.82% | 668.54% | 676.99% |
|
|
|||||
| Common Stock & APIC | 2.99% | 2.97% | 2.76% | 2.75% | 3.09% |
| Retained Earnings | -30.91% | -31.12% | -24.75% | -23.99% | -23.59% |
| Treasury Stock & Other | -139.01% | 34.03% | -17.74% | 253.56% | 219.36% |
| Total Common Equity | -70.39% | -57.90% | -42.77% | -34.45% | -27.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -70.39% | -57.90% | -42.77% | -34.45% | -27.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -70.39% | -57.90% | -42.77% | -34.45% | -27.85% |
|
|
|||||